Natalie C. Holles Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Natalie C. Holles.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Natalie C. Holles. Natalie C. Holles is a SVP, Business Development in HYPERION THERAPEUTICS INC ($HPTX) and a SVP, Corp & Business Dev in HYPERION THERAPEUTICS INC ($HPTX) and a Director in Allakos Inc. ($ALLK) and a President and COO in Audentes Therapeutics, Inc. ($BOLD) and a Senior Vice President, COO in Audentes Therapeutics, Inc. ($BOLD) and a Director in Rubius Therapeutics, Inc. ($RUBY).
Address: C/O HYPERION THERAPEUTICS, INC. 601 GATEWAY BOULEVARD, SUITE 200 SOUTH SAN FRANCISCO 94080 CA
Companies in which Natalie C. Holles is an Insider
Allakos Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Natalie C. Holles: Director
Holdings: 0 shares
Latest Transaction: Jan 06 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Audentes Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Natalie C. Holles: President and COO, Senior Vice President, COO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 15 2020
$BOLD Market Capitalization: $337.82M
$BOLD Previous Close: $15.83
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HYPERION THERAPEUTICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Natalie C. Holles: SVP, Business Development, SVP, Corp & Business Dev
Holdings: 0 shares
Latest Transaction: May 08 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Rubius Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Natalie C. Holles: Director
Holdings: 0 shares
Latest Transaction: May 13 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Natalie C. Holles
Sentiment: All, ALLK, BOLD, HPTX, RUBY
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | RUBY | Rubius Therapeutic ... | Holles Natalie C. | Director | Option Exercise | A | 23.25 | 25,000 | 581,250 | 25,000 | |
| Jan 06 2021 | ALLK | Allakos Inc. | Holles Natalie C. | Director | Option Exercise | A | 133.77 | 4,000 | 535,080 | 4,000 | |
| May 26 2020 | RUBY | Rubius Therapeutic ... | Holles Natalie C. | Director | Option Exercise | A | 6.22 | 25,000 | 155,500 | 25,000 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Holles Natalie C. | President and COO | Option Exercise | D | 24.74 | 50,105 | 1,239,598 | 0 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Holles Natalie C. | President and COO | Option Exercise | D | 36.39 | 25,000 | 909,750 | 0 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Holles Natalie C. | President and COO | Option Exercise | D | 27.39 | 93,109 | 2,550,256 | 0 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Holles Natalie C. | President and COO | Option Exercise | D | 15.26 | 40,883 | 623,875 | 0 |